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Background: Acute ischemic stroke (AIS) is inﬂuenced by gender, age, and the brain site affected. Better charac-
terization of AIS is necessary for improving guidelines, prevention, and destination of resources.
Methods: Demographics, prestroke conditions, etiology, subtypes, speciﬁc hospital outcome, clinical and labora-
tory parameters, and mortality rates were prospectively registered in 105 southern Italian patients.
Results: AIS becamemore frequent inwomen than inmen after age 65 years. Cryptogenic AIS decreasedwith age
independently of sex and lesion site. Cerebellum–brainstem strokewasmore prevalent inmen,whereas anterior
AIS was more frequent in women. There were no overall differences in 6- and 12-month survival rates based on
site or sex; however, mortality rates were high after age 80 years. Chronic kidney disease was more frequent in
patients with cerebellum–brainstem stroke, and its prevalence increased signiﬁcantlywith age independently of
sex. Association of AIS with arterial hypertension, diabetes, and previous myocardial infarction increased with
age, whereas that with active smoking decreased with age, independently of sex and site.
Conclusion: Speciﬁc AIS etiology and blood characteristics associated independently to the youngest and oldest
AIS patients, respectively. Chronic kidney diseasewas a speciﬁc predictor of cerebellum–brainstemAIS. AISmor-
tality showed peculiar association with the oldest patients.© 2014 Elsevier B.V. All rights reserved.1. Introduction
Acute ischemic stroke (AIS) imparts a tremendous medical, emo-
tional, and ﬁscal burden on society. Moreover, annual costs for stroke
care are increasing. According to the World Health Organization statis-
tics, the incidence and prevalence of stroke are 9.0 million and 30.7 mil-
lion, respectively, with a higher incidence found in the eastern Paciﬁc,
Europe, and southeast Asia. Due to advances in Western healthcare,
the prevalence of stroke since 1970 has decreased 42%, whereas it has
more than doubled in low-income to middle-income countries [1].
However, fatal stroke remains the third cause of death worldwide,y Unit, IRCCS INM Neuromed,
7575.
@unisa.it (C. Vecchione).
ights reserved.accounting for 10% (5.5 million) of deaths; cancer, the ﬁrst cause,
accounts for 12% (7.1 million). In addition, AIS produces severe depen-
dency after 4 weeks in approximately one-third of patients hospitalized
[2]. Non-fatal stroke is the main cause of disability in Italy [3].
Stroke (ICD-9 codes: 430–438) is associatedwith the elderly and the
female sex. The frequency of AIS increases usually after 40 years of age
[4], and in theWest it is estimated that only a quarter of stroke-affected
people are under the age of 65 years. It is considered one of the diseases
that develops due to long-lasting exposure to risk factors associated
with the “modern” lifestyle, such as smoking cigarettes, alcohol/drugs
abuse, an unbalanced diet and obesity, diabetes, constant stress, and
not taking regular medical check-ups [5]. The incidence and mortality
of AIS are also affected by disparities in access to high-quality care and
education [6], by misdiagnosing venous thromboembolism and, there-
fore, failing to administer prophylaxis during admission to Stroke
Units (SU) [7], by the antithrombotic drug prescribed, and by AIS
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SU [8].
The disease severity proﬁles have changed over the last decade on
account of the expansion of primary and secondary prevention, but
AIS continues to be themain complication of atrial ﬁbrillation [9], inter-
nal carotid artery occlusion [10], myocardial infarction (MI) [11], ath-
erosclerotic vascular disease [12], diabetes mellitus (DM) [13], chronic
kidney disease (CKD) [14], chronic obstructive pulmonary disease
[15], metabolic dysfunction [16], and dyslipidemia [17]. The accurate
clinical evaluation of AIS patients on admission by the SU team is
therefore fundamental for developing an appropriate strategy for care
in the intermediate- and long-term. Unfortunately, clinicians use non-
standardized approaches for AIS prognosis based on clinical experience
and knowledge gathered from the international and national guidelines.
These guidelines are based on the characteristics of well-studied pop-
ulations, especially from northern Europe, such as Scandinavians
[18,19]. In fact, nationwide characterization of well-known prestroke
and stroke factors in all social backgrounds is essential if we are to
have an impact on the rapid increase of AIS in our aging populations
[20]. However, populations can differ signiﬁcantly not only in their
socio-behavioral, legal, and geographical conditions, but also from
other, historically understudied, cohorts [21]. The Italian population isTable 1
Characteristics of patients who developed acute ischemic stroke stratiﬁed by age group.
Characteristics (%) ≤49.9 years
No. 20
6-month mortality ND
12-month mortality ND
Prestroke
Active smoking status 40.0
Arterial hypertension 55.0
Aspirin use 10.0
Contraceptive use 5.0
Chronic kidney disease 25.0
Diabetes mellitus II type 10.0
Dyslipidemia 35.0
Family risk assessment 20.0
Hyperhomocysteinemia 10.0
Infection inﬂammatory status ND
Migraine history 5.0
Previous stroke 10.0
Thrombophilic screening abnormalities 10.0
Transient ischemic attack 5.0
Weekend admission 55.0
Stroke related
Arteriosclerotic vascular disease 15.0
Cardioembolism 15.0
Cryptogenic etiology 55.0
Disease of the small vessels 10.0
Anterior stroke 45.0
Blood characteristics
Albumin lowest quartile 5.0
ESR highest quartile 5.0
Fibrinogen 3rd quartile 15.0
Triglycerides 3rd quartile 10.0
Medical complications
Atrial septum aneurysm 5.0
Carotid pathology including carotid stenosis b70% 35.0
Chronic atrial ﬁbrillation ND
Dilated cardiomyopathy ND
Heart failure ND
Myocardial infarction less than 3 months ND
Paroxysmal atrial ﬁbrillation ND
Patent foramen ovale 35.0
Peripheral artery disease ND
Previous myocardial infarction N3 months 5.0
Thrombus in the atrium ND
Valvular prosthesis ND
⁎ p b 0.05 between aged ≤49.9 years and aged ≥80 years.one that has not been fully characterized over the last decade. In partic-
ular, Molise is one of the remaining regions in Europe without stroke
registry surveillance, and, as such, is of great interest for the characteri-
zation of AIS patients from geographical and socio-behavioral points of
view.
Here, we characterize AIS in patients from the Molise region, strati-
fying data for age, sex, and lesion site.
2. Methods
For detailedmethodology, please see the online-only supplementary
material.
3. Results
The principal patient characteristics stratiﬁed by age are given in
Table 1. Cardioembolism was the main cause of AIS in our population:
it was more common after 80 years of age and, considering the Oxford-
shire Community Stroke Project (OCSP) classiﬁcation, was associated
with total anterior circulation syndrome (TACS) and partial anterior
circulation syndrome (PACS). Moreover, very old AIS patients had a sig-
niﬁcantly higher erythrocyte sedimentation rate (ESR) and a lower50–80 years N80 years p⁎
71 14
8.5 21.4 NA
1.4 49.9 NA
12.7 7.2 b0.001
87.3 100.0 0.003
21.1 35.7 0.06
4.2 ND NA
45.1 71.4 0.007
43.7 57.1 0.003
56.3 14.3 0.18
5.6 ND NA
5.6 ND NA
22.5 28.6 NA
5.6 ND NA
11.3 7.2 0.77
ND ND NA
2.8 7.2 0.80
45.1 35.7 0.27
21.1 14.3 0.95
35.2 78.6 b0.001
32.4 7.1 0.004
9.9 7.1 0.77
62.0 64.3 0.26
23.9 64.3 b0.001
23.9 28.6 0.05
25.4 21.4 0.63
26.8 28.6 0.16
4.2 ND NA
66.2 64.3 NA
7.0 57.1 NA
11.3 14.3 NA
2.8 14.3 NA
4.2 ND NA
14.1 7.1 NA
11.3 ND NA
1.4 ND NA
14.1 35.7 0.02
8.5 7.1 NA
2.8 ND NA
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with PACS and with posterior circulation syndrome (POCS), while the
quartile of low albumin level was associated with TACS. Active smoking
and a cryptogenic etiology were more common before age 50, whereas
aspirin use, arterial hypertension, DM, CKD, and a history of MI were
more common after age 80. OCSP analysis revealed that arterial hyper-
tension was associated with TACS and lacunar syndrome (LACS).
Dyslipidemia was more prevalent in the adult and old groups com-
pared with the young and very old groups (data not shown). Smoking
is known to enhance atherosclerosis leading to large-vessel disease
[22]: we found that the proportion of smokers was the greatest in the
young AIS group, and decreased from adult to the very old patients
(N80 years). The highest 6- and 12-month mortality rates were found
in very old patients.
The principal stroke characteristics stratiﬁed by sex are given in
Table 2. AIS increased in prevalence in women after age 65 and in
men before age 65. The proportion of women with anterior stroke wasTable 2
Characteristics of patients who developed acute ischemic stroke stratiﬁed by gender.
Characteristics (%) Total Women Men p⁎
No. 105 46 59
6-month mortality 8.6 6.5 10.2 0.51
12-month mortality 16.2 19.6 13.6 0.17
Age category (years)
≤49.9 19.1 15.3 22.0 0.006
≥50–64.9 34.3 21.7 44.1
≥65–79.9 33.3 41.3 27.1
≥80 13.3 21.7 6.8
Prestroke
Active smoking status 17.1 10.9 22.0 0.13
Arterial hypertension 82.9 84.8 81.4 0.64
Aspirin use 20.9 26.1 16.9 0.25
Contraceptive use 3.8 8.7 NA ND
Chronic kidney disease 44.8 45.7 44.1 0.87
Diabetes mellitus II type 39.1 41.3 37.3 0.67
Dyslipidemia 46.7 54.3 40.6 0.16
Family risk assessment 7.6 4.3 10.2 0.06
Hyperhomocysteinemia 5.7 4.3 6.8 0.59
Infection inﬂammatory status 19.1 21.7 16.9 0.38
Migraine history 4.8 6.5 3.4 0.45
Previous stroke 10.5 13.0 8.5 0.44
Thrombophilic screening abnormalities 1.9 2.2 1.7 0.85
Transient ischemic attack 3.8 ND 6.8 ND
Weekend admission 45.7 54.3 38.9 0.12
Stroke related
Arteriosclerotic vascular disease 19.0 17.4 20.3 0.15
Cardioembolism 37.1 45.6 30.5 0.11
Cryptogenic etiology 33.3 26.1 38.9 0.16
Disease of the small vessels 9.5 10.9 8.5 0.67
Anterior stroke 59.1 71.7 49.2 0.02
Blood characteristics
Albumin lowest quartile 23.8 30.4 18.6 0.15
ESR highest quartile 25.7 34.8 18.6 0.06
Fibrinogen 3rd quartile 22.9 19.6 8.5 0.09
Platelets 3rd quartile 23.8 23.9 23.7 0.98
Triglycerides 3rd quartile 24.8 23.9 25.4 0.85
Medical complications
Atrial septum aneurysm 3.8 8.7 ND ND
Carotid pathology including carotid stenosis b70% 60.0 60.9 59.3 0.87
Chronic atrial ﬁbrillation 17.1 23.9 11.9 0.10
Dilated cardiomyopathy 9.5 8.7 10.2 0.79
Heart failure 3.8 4.3 3.4 0.79
Myocardial infarction less than 3 months 2.9 ND 5.1 ND
Paroxysmal atrial ﬁbrillation 10.5 10.9 10.2 0.9
Patent foramen ovale 14.3 23.9 6.8 0.01
Peripheral artery disease 0.9 ND 1.7 ND
Previous myocardial infarction N3 months 14.3 15.2 13.6 0.80
Thrombus in the atrium 6.7 8.7 5.1 0.46
Valvular prosthesis 1.9 4.3 ND ND
⁎ p b 0.05 between women and men.greater than that of men, whereas the majority of men presented with
cerebellum–brainstem stroke. The mean age for women AIS patients
was greater than that for men. Cardioembolism was more common in
women than in men. In women, AIS was associated with an elevated
ESR and high ﬁbrinogen levels. The 6- and 12-month mortality rates
were not found signiﬁcantly different between men and women. How-
ever, higher 6-month mortality was found for men, whereas higher 12-
monthmortalitywas found forwomen. Familial riskwasmore common
inmen. The anterior brainwas found to be signiﬁcantlymore affected in
women than in men. The presence of patent foramen ovale (PFO) was
signiﬁcantly greater in women. The principal patient characteristics
stratiﬁed for stroke location are given in Table 3. The 6- and 12-month
mortality rateswere not signiﬁcantly different for anterior- and cerebel-
lum–brainstem-stroke patients. Patients with b70% carotid stenosis
more commonly developed stroke of the cerebellum–brainstem. UsingTable 3
Characteristics of patients who developed acute ischemic stroke stratiﬁed by brain site
location.
Characteristics (%) Anterior Cerebellum–
brainstem
p⁎
No. 62 43
6-month mortality 9.6 6.9 0.62
12-month mortality 14.6 18.6 0.32
Age category (years)
≤49.9 14.5 25.6 0.80
≥50–64.9 38.7 27.9
≥65–79.9 32.3 34.9
≥80 14.5 11.6
Prestroke
Active smoking status 17.7 16.3 0.84
Arterial hypertension 87.1 76.7 0.17
Aspirin use 19.4 23.3 0.63
Contraceptive use 3.2 4.7 0.70
Chronic kidney disease 37.1 55.8 b0.05
Diabetes mellitus II type 38.7 39.5 0.93
Dyslipidemia 53.2 37.2 0.11
Family risk assessment 8.1 6.9 0.84
Hyperhomocysteinemia 4.8 6.9 0.64
Infection inﬂammatory status 21.0 16.3 0.54
Migraine history 3.2 6.9 0.37
Previous stroke 8.1 13.9 0.33
Thrombophilic screening abnormalities 1.6 2.3 0.79
Transient ischemic attack 4.8 2.3 0.50
Weekend admission 41.9 51.2 0.35
Stroke related
Arteriosclerotic vascular disease 22.6 13.9 0.27
Cardioembolism 38.7 34.9 0.69
Cryptogenic etiology 29.0 39.5 0.26
Disease of the small vessels 9.6 9.3 0.95
Blood characteristics
Albumin lowest quartile 22.6 25.6 0.72
ESR highest quartile 24.2 27.9 0.67
Fibrinogen 3rd quartile 27.4 16.3 0.18
Platelets 3rd quartile 25.8 20.9 0.56
Triglycerides 3rd quartile 21.0 30.2 0.28
Medical complications
Atrial septum aneurysm 6.5 ND ND
Carotid pathology including carotid stenosis
b70%
53.2 69.8 0.08
Chronic atrial ﬁbrillation 19.4 13.9 0.47
Dilated cardiomyopathy 8.1 11.6 0.54
Heart failure 4.8 2.3 0.51
Myocardial infarction less than 3 months 17.7 9.3 0.22
Paroxysmal atrial ﬁbrillation 11.3 9.3 0.74
Patent foramen ovale 12.9 16.3 0.63
Peripheral artery disease 1.6 ND ND
Previous myocardial infarction N3 months 1.6 4.7 0.36
Thrombus in the atrium 4.8 9.3 0.37
Valvular prosthesis 3.2 ND ND
⁎ p b 0.05 between Anterior and Cerebellum–brainstem.
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andmigraine history were signiﬁcantly associated with LACS and POCS.
Transient ischemic attack, the 3rd quartile of platelets, and triglycerides
were associated with LACS. Finally, chronic atrial ﬁbrillation was more
frequently associated with TACS and PACS. No other signiﬁcant differ-
ences were found between age groups, sexes, or lesion sites.
4. Discussion
Here we assess the age and gender variances of stroke in different
brain sites and the risk factor proﬁle with clinical outcome. Compared
with the young onset group, the old onset group had signiﬁcantly differ-
ent risk proﬁles and stroke features. Several stroke risk factors weremore
prevalent in the elderly (infection, DM, hypertension, CKD, carotid pa-
thology including carotid stenosis, transient ischemic attack, chronic atri-
al ﬁbrillation, dilated cardiomyopathy, and previously studied blood
biomarkers). Six- and 12-month mortality rates in the very old popula-
tion contributed, respectively, to one-ﬁfth and one-half of deaths in our
study. Aspirin use before strokewasmore common in the very old popu-
lation, in particular in the women of this group, and was associated with
the incidence of AIS. Other studies support that regular aspirin usemaybe
associatedwith increased rates of ischemic stroke in low-risk populations
[23], with increased systolic blood pressure, and with antagonization of
the effect of certain antihypertensive drugs [24,25]. The thrombogenicTable 4
Oxfordshire Community Stroke Project (OCSP) classiﬁcation.
Characteristics (%) TACS(%) PACS(%) LACS(%) POCS(%) TACS vs
PACS
No. 17 34 16 36
Prestroke
Active smoking status 11.8 23.5 18.75 13.9 n.s
Arterial hypertension 88.2 85.3 87.5 75 n.s
Aspirin use 11.8 23.5 25 22.2 n.s
Contraceptive use 5.9 2.9 6.2 2.8 n.s
Chronic kidney disease 64.7 29.4 31.2 55.5 b0.001
Diabetes mellitus II type 35.3 38.2 43.7 38.9 n.s
Dyslipidemia 47.0 50.0 56.2 38.9 n.s
Family risk assessment 11.8 5.9 6.2 8.3 n.s
Hyperhomocysteinemia 0.0 2.9 12.5 5.6 n.s
Infection inﬂammatory status
Migraine history 5.9 0.0 12.5 5.6 0.04
Previous stroke 0.0 11.8 12.5 13.9 0.001
Thrombophilic screening abnormalities 0.0 11.8 12.5 13.9 n.s
Transient ischemic attack 0.0 2.9 12.5 2.7 n.s
Weekend admission 35.3 52.9 43.7 44.4 n.s
Stroke related
Arteriosclerotic vascular disease 29.4 20.6 18.7 13.9 n.s
Cardioembolism 47.0 44.1 18.7 36.1 n.s
Cryptogenic etiology 23.5 23.5 50 38.9 n.s
Disease of the small vessels 0 11.8 12.5 8.3 0.001
Blood characteristics
Albumin lowest quartile 41.2 17.6 12.5 27.8 b0.001
ESR highest quartile 11.8 23.5 12.5 27.8 0.04
Fibrinogen 3rd quartile 29.4 23.5 25 22.2 n.s
Platelets 3rd quartile 5.9 32.3 37.5 19.4 b0.001
Triglycerides 3rd quartile 5.9 17.6 43.7 30.6 b0.01
Medical complications
Atrial septum aneurysm 5.9 5.9 6.25 0 n.s
Chronic atrial ﬁbrillation 35.3 23.5 0 11.1 n.s.
Paroxysmal atrial ﬁbrillation 11.8 8.8 12.5 11.1 n.s.
Patent foramen ovale 17.6 11.8 12.5 16.7 n.s.
Previous myocardial infarction
N3 months
23.5 14.7 12.5 11.1 n.s.
Chi-square test was used to compare values of all parameter. TACS indicates total anterior circul
POCS, posterior circulation syndrome.
⁎ P value is statistically signiﬁcant.effects of aspirin have been demonstrated experimentally, particularly
at high doses, and possibly relate to inhibition of endothelial-derived
prostacyclin synthesis or, in somepatients, to an increase in platelet adhe-
siveness [26]. However, the mechanisms by which frequent aspirin use
could increase ischemic stroke are still not well deﬁned.
In our population, hypertension remained a prominent risk factor for
AIS, and, as expected, the risk of stroke increased with age, as for other
populations [27,28]. However, this increase in risk was most notable in
individuals without evidence of hypertension at the beginning of their
follow-up period; thus, while the risk of stroke rose with age in hy-
pertensive men, it increased more rapidly in normotensive men. The
percentage of stroke attributable to hypertension also declined signiﬁ-
cantlywith age, again secondarily to the increasing importance of stroke
inmenwithout hypertension. Thus, while hypertension remains an im-
portant risk factor for stroke in the elderly [29], it appears that other fac-
tors associated with aging have an increasing role in the causation of
stroke in other individuals.
On this point, studies have reported that DM independently in-
creases the risk of death by a factor of 1.5 to 2 [30]. Our ﬁndings demon-
strate that ischemic strokewas signiﬁcantlymore correlatedwithDM in
our very old population, which had the greatest 12-month mortality
level. Moreover, the risk of stroke was signiﬁcantly associated CKD in
the old age group, independently of demographics, lipid levels, smok-
ing, and other known factors that predict stroke. Interestingly, CKDTACS vs
LACS
TACS vs
POCS
PACS vs
LACS
PACS vs
POCS
LACS vs
POCS
p⁎
n.s n.s n.s n.s n.s 0.15
n.s 0.025 n.s n.s 0.037 0.05
n.s n.s n.s n.s n.s 0.11
n.s n.s n.s n.s n.s 0.65
b0.001 n.s n.s b0.001 b0.001 b0.001
n.s n.s n.s n.s n.s 0.91
n.s n.s n.s n.s n.s 0.13
n.s n.s n.s n.s n.s 0.54
n.s 0.05 0.023 n.s n.s b0.05
n.s n.s b0.001 0.05 n.s 0.04
b0.001 b0.05 n.s n.s n.s 0.003
n.s b0.05 0.023 n.s n.s 0.014
b0.001 n.s 0.023 n.s 0.02 b0.001
n.s n.s n.s n.s n.s 0.12
n.s 0.01 n.s n.s n.s 0.068
b0.001 n.s b0.001 n.s 0.01 b0.001
b0.001 0.02 b0.001 0.02 n.s b0.001
b0.001 0.009 n.s n.s n.s b0.001
b0.001 n.s n.s n.s 0.01 b0.05
n.s 0.008 n.s n.s 0.01 0.007
n.s n.s n.s n.s n.s 0.91
b0.001 b0.001 n.s 0.05 0.008 b0.05
b0.001 b0.001 b0.001 0.04 n.s b0.05
n.s n.s n.s n.s n.s 0.12
b0.001 b0.001 b0.001 0.03 n.s 0.002
n.s. n.s. n.s. n.s. n.s n.s
n.s. n.s. n.s. n.s. n.s 0.761
n.s. n.s. n.s. n.s. n.s 0.088
ation syndrome; PACS, partial anterior circulation syndrome; LACS, lacunar syndrome; and
45A. Kisialiou et al. / Journal of the Neurological Sciences 339 (2014) 41–46was associated with cerebellum–brainstem-localized AIS independent-
ly of gender and, using the OCSP classiﬁcation, it resulted associated
with POCS.
We also found signiﬁcant evidence of association of hyper-
tension, DM, and CKD with AIS. In particular, there was a 2-fold in-
crease for hypertension, an ~6-fold increase for DM, and an ~3-fold
increase for CKD in the very old population compared with the
young group.
When analyzing extravascular pathologies, a signiﬁcant association
was found in very old patients between AIS and MI occurring b3
months previously. In particular, the prevalence of stroke in this
group was more than 7-fold that in young patients, independently of
gender or the site of lesion. This fact indicates that an appropriate
follow-up of elderly patients should be performed after non-fatal MI
by a multidisciplinary team of cardiologists and neurologists. In addi-
tion, PFO, which is present in N25% of the adult population [31], was sig-
niﬁcantly associatedwith incidence ofmajor ischemic stroke inwomen.
Patients with PFO are probably more susceptible to atrial arrhythmias
and intra-atrial thrombus formation, which lead to stroke. Of note,
cardioembolism was signiﬁcantly associated with stroke in the very
old group, independently of gender or lesion site. Thus, cardioembolism
and PFO may be important risk factors for stroke in the elderly and in
women, respectively.
In a previous paper [32], we reported an association between the ex-
tent of ischemia and albumin levels and ESR. In the present study, we
further highlight this association, showing that low albumin levels and
high ESR are characteristics of a very old populationwith stroke, and in-
crease the risk of cerebral damage in this group. In females, we also
found association of stroke with high ESR and normal–high ﬁbrinogen
levels. This ﬁnding should be addressed in future studies.
The presence of undetermined stroke etiology in the young patient
group could be due to a genetic background not analyzed in our study
or to problemswith anamnesis in this group of patients (drug abuse, al-
cohol abuse, work stress, asocial lifestyle, etc.). Particularly, 20% of the
young population had a family risk of stroke, and 10% had a history of
previous stroke. In addition, previous stroke and thrombophilic screen-
ing abnormalities were found associated with POCS. Moreover, 55% ex-
perienced stroke during a weekend, indicative of an association with
lifestyle and, in particular, with substance abuse. In fact, we found that
ischemic stroke was associated with active smoking and a cryptogenic
etiology in young patients, rather than with hypertension, DM, MI,
CKD, cardioembolism, low plasma albumin, or ESR, as for very old
patients.
In conclusion, prospective epidemiologic proﬁling (by age, sex, and
lesion site) of AIS patients is fundamental for characterization of our his-
torically understudied population. The trends identiﬁed in this pilot
study and all the ﬁndings, like the key outcomes that should be further
studied and replicated for use in good clinical practice guidelines of SUs,
will be addressed in a clinical stroke registry.
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